ACL: Alcon Inc. Twitter on Stock

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, June 21, 2011, 2:57 PM Maxim Group initiates Affymetrix (AFFX +8.3%) with a buy, saying the company is well positioned to benefit from improved demand for microarrays in the second half of the year. It has a string of new products, and a new distribution agreement with Thermo Fisher (TMO +2%). Comment! [Healthcare]
Friday, June 17, 2011, 2:59 PM Buyers of Merit Medical's (MMSI -3.1%) secondary are 'in the green' as the stock bounces 6% from this morning's offering. Older owners may be less pleased as the stock is solidly lower than yesterday's close. Comment! [Healthcare]
Monday, April 25, 2011, 12:10 AM Notable earnings after Monday's close: ACL, AGNC, AMP, ESRX, HLX, HMA, JEC, MAS, NFLX, PCL, RSH, UIS, VECO 1 Comment
Wednesday, January 26, 2011, 12:10 AM Notable earnings after Wednesday's close: ACL, AMLN, CCI, CTXS, DRE, ETFC, HRC, LOGI, LRCX, LSI, MMI, MUR, NE, NFLX, OI, QCOM, RHI, SBUX, SYMC, TER Comment! [Earnings]
Wednesday, December 15, 2010, 3:08 AM Novartis (NVS) will merge with Alcon (ACL) in a deal worth $12.9B, paying Alcon $168 per share for the 23% stake Novartis doesn't already own. Novartis will reactivate a share buyback to minimize shareholder dilution. (PR) Comment!
Wednesday, September 22, 2010, 9:36 AM Apple (AAPL) sits atop Goldman's VIP list of hedge fund holdings. Rounding out the top 10: JPM, PFE, BAC, MSFT, C, ACL, GOOG, XOM, MA. Comment!
Thursday, August 26, 2010, 8:20 AM Following the completion of its Alcon (ACL) stake sale for $28.3B, Nestle (NSRGY.PK) says it will "substantially" reduce its net debt of 29.6B Swiss francs ($29B) and aims to maintain its AA rating. Analysts expect an additional buyback and/or bolt-on acquisitions in the short term. (PR) Comment!
Thursday, August 26, 2010, 7:39 AM Nestle (NSRGY.PK) completes the sale of its remaining shares in Alcon (ACL) to Novartis (NVS) for $28.3B in cash. Novartis is now Alcon's majority shareholder, with control of approximately 77% of Alcon's outstanding shares. (PR) Comment!
Monday, August 16, 2010, 12:09 PM Novartis (NVS) signaled it may yet raise a $9.8B offer in order to buy out minority shareholders in Alcon (ACL +1.5%), including SAC Capital and York. Existing plans have Novartis paying public shareholders slightly less after buying out Nestle's (NSRGY.PK) 52% stake. Comment!
Wednesday, June 30, 2010, 11:15 AM Nestle (NSRGY.PK) will get $28.1B when it's paid for its Alcon (ACL) stake in H2, prompting questions about just what to do with that much cash; some investors are advocating an expansion in emerging markets to keep up with rival Unilever (UN). Comment!
Thursday, February 11, 2010, 6:06 PM Alcon (ACL): Q4 EPS of $1.61 beats by $0.10. Revenue of $1.7B (+15%) vs. $1.6B. (PR) Comment!
Thursday, February 11, 2010, 12:10 AM Notable earnings after Thursday's close: ACL, BGC, CAKE, CEPH, DCT, MFE, PM, RSG Comment!
Wednesday, January 20, 2010, 11:25 AM Directors at Alcon (ACL +0.6%) slam an offer by Novartis (NVS -0.7%) to acquire Alcon's remaining shares as "grossly inadequate" and "offensive." The price that Novartis is paying Nestle (NSRGY.PK) for its portion of the eye-care giant is some 20% higher than the price it would pay minority shareholders in the public market. (previously) Comment!
Tuesday, January 12, 2010, 8:25 AM A Mass. pension fund is suing Alcon (ACL), Novartis (NVS) and Nestle (NSRGY.PK) over their recent deal, saying the terms are discriminatory because Nestle will receive significantly more per share than minority shareholders will. The suit seeks to block the merger, or at least to recover damages. Comment!
Tuesday, January 5, 2010, 9:12 AM Analysts believe Novartis (NVS) will raise its offer for Alcon (ACL) to the $170-180 range, from $148, to satisfy minority shareholders. While Novartis CEO Daniel Vasella seems to believe he can defend paying Nestle more than other shareholders, it's going to be a tough sell. After dropping 5.7% Monday, ACL is +0.8% premarket to $156.22. Comment!
Tuesday, January 5, 2010, 2:49 AM Round and round the money goes. After agreeing to sell its stake in Alcon (ACL), Nestle (NSRGY.PK) is buying Kraft's (KFT) frozen pizza unit for $3.7B in cash. Kraft, in turn, is using the funds to raise its hostile bid for Cadbury (CBY) by 60 pence ($0.97) per share. (PR I, II) Comment!

ACL Alcon Inc.

ACL

Alcon Inc.